Scigen Limited is engaged in developing, manufacturing, and marketing recombinant human health care biotechnology derived products including human growth hormone, human insulin and human GCSF. The company focuses in the areas of endocrinology, gastroenterology and immunology. Scigen Limited is headquartered in Singapore with in Australia, China, India, Korea, Philippines and Vietnam, partners and distributors in all other countries. The company operates as a subsidiary of Bioton S.A.
Suite 1,13b Narabang Way,Belrose
Sydney; New South Wales; Postal Code: 2085
Contact Details: Purchase the Scigen Pte. Ltd. report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.Request a demo of the EMIS service
To view more information, Request a demonstration of the EMIS service